DKDavid M. Kuehn

David M. Kuehn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David M. Kuehn has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • MDCT imaging of the stomach: advances and applications

    by Prashant Nagpal, Anjali Prakash, Gaurav Pradhan, Aditi Vidholia, Nishant Nagpal, Sachin S Saboo, David M Kuehn, Ashish Khandelwal

    The stomach may be involved by a myriad of pathologies ranging from benign aetiologies like inflammation to malignant aetiologies like carcinoma or lymphoma. Multidetector CT (MDCT) of the stomach is the first-line imaging for patients with suspected gastric pathologies. Conventionally, CT imaging had the advantage of simultaneous detection of the mural and extramural disease extent, but advances in MDCT have allowed mucosal assessment by virtual endoscopy (VE). Also, better three-dimensional (3D) post-processing techniques have enabled more robust and accurate pre-operative planning in patients undergoing gastrectomy and even predict the response to surgery for patients undergoing laparoscopic sleeve gastrectomy for weight loss. The ability of CT to obtain stomach volume (for bariatric surgery patients) and 3D VE images depends on various patient and protocol factors that are important for a radiologist to understand. We review the appropriate CT imaging protocol in the patients with suspected gastric pa...


  • Open Access

    Tumor grade of clear cell renal cell carcinoma assessed by contrast-enhanced computed tomography

    by Kousei Ishigami, Leandro V. Leite, Marius G. Pakalniskis, Daniel K. Lee, Danniele G. Holanda, David M. Kuehn

    The purpose of this study was to clarify the association between CT findings and Fuhrman grade of clear cell renal cell carcinoma (ccRCC). The study group consisted of 214 surgically proven ccRCC in 214 patients. Contrast-enhanced CT studies were retrospectively assessed for tumor size, cystic versus solid, calcification, heterogeneity of lesions, percentage of non-enhancing (necrotic) areas, and growth pattern. CT findings and Fuhrman grade were compared. Nineteen of 22 (86.4%) cystic ccRCC were low grade (Fuhrman grades 1-2). There was no significant correlation between tumor size and grade in cystic ccRCC (P = 0.43). In predominantly solid ccRCC, there was significant correlation between tumor size and grade (P < 0.0001). Thirty-eight of 43 (88.4%) infiltrative ccRCC were high grade (Fuhrman grades 3-4). Logistic regression showed tumor size and infiltrative growth were significantly associated with grades 3-4 (P = 0.00083 and P = 0.0059). Cystic ccRCC tends to be low grade. Infiltrative growth and larger tumor size may increase the likelihood of high grade ccRCC.


  • Detectability of pancreas divisum in patients with acute pancreatitis on multi-detector row computed tomography

    by Yoshiki Asayama, Wei Fang, Alan Stolpen, David Kuehn

    The purpose of this study was to retrospectively assess the diagnostic performance of multi-detector row computed tomography (MDCT) in an evaluation of pancreas divisum using endoscopic retrograde pancreatography (ERP) as the reference standard. We analyzed 41 consecutive patients (14 cases of pancreas divisum and 27 cases of standard anatomy) who had undergone both MDCT and ERP for the evaluation of clinically diagnosed acute pancreatitis between November 2004 and June 2007. The CT reconstruction thickness and interval were both 3 mm. Two radiologists independently reviewed CT data, and the diagnostic confidence in determining the pancreatic ductal anatomy was scored using a five-point scale. CT detectability was correlated with the severity of pancreatitis and the degree of pancreatic necrosis based on the Balthazar index. With consensus, 16 of 41 cases (39.0%) were evaluated as indeterminate. Ductal anatomy was correctly diagnosed in 23 of 41 cases (56.1%). Eight of 14 cases (57.1%) were correctly diagnosed as pancreas divisum. Standard anatomy was identified in 15 of 27 cases (55.6%). The inter-observer agreement was substantial (κ = 0.71). Grade B or more pancreatitis and the presence of pancreatic necrosis significantly influenced the evaluation of ductal anatomy (p = 0.01 and p < 0.01, respectively). Pancreas divisum was correctly diagnosed in the case of grade A acute pancreatitis. The CT detectability of pancreas divisum in patients with grade B or more pancreatitis is still relatively low even in the MDCT era.


  • Safety of Ultrasound-Guided Fine Needle Aspiration Biopsy of Neck Lesions in Patients Taking Antithrombotic/Anticoagulant Medications

    by Monzer M. Abu-Yousef, Joshua H. Larson, David M. Kuehn, Andrew S. Wu, Archana T. Laroia

    We examined records of patients who underwent ultrasound-guided fine needle aspiration biopsy (USGFNAB) of neck lesions to determine whether there was a significantly increased incidence of bleeding complications in patients on antithrombotic and/or anticoagulant (AT/AC) medications compared to patients not receiving AT/AC therapy. Our institutional review board approved this Health Insurance Portability and Accountability Act-compliant retrospective examination of patients' medical data without requiring informed consent. The records of 593 patients (422 women and 171 men ranging from 18 to 91 years of age) who underwent USGFNAB of 788 total neck lesions over an 18-month period were reviewed to determine AT/AC medication used and evidence of USGFNAB-related bleeding complications. Of these, 144 patients (24.3%) were taking one or more AT/AC medications including aspirin, clopidogrel, heparin, and warfarin. The χ2 test was used to assess statistically significant differences in the incidence of USGFNAB-related bleeding complications between patients who were on daily AT/AC medications (test group) and patients who were not (control group). Six USGFNAB-related hematomas (1.0%) occurred. Two hematomas developed in patients on AT/AC medications, and 4 hematomas developed in patients who did not take AT/AC medications (χ2 = 0.27, df = 1, P = 0.603). This study shows no statistically significant difference in the incidence of hematoma formation after USGFNAB of neck lesions in patients taking AT/AC medications compared to patients not taking AT/AC medications. On the basis of these data, there is no benefit, with regard to incidence of bleeding complications, to discontinuing AT/AC medications in patients undergoing USGFNAB of neck masses.


  • Management Algorithm for Pneumatosis Intestinalis and Portal Venous Gas: Treatment and Outcome of 88 Consecutive Cases

    by Erik Wayne, Matthew Ough, Andrew Wu, Junlin Liao, K. J. Andresen, David Kuehn, Neal Wilkinson


  • Open Access

    Ultrasound-Guided Needle Localization of Recurrent Paratracheal Thyroid Cancer

    by Aaron M. Fletcher, Todd W. Preston, David M. Kuehn, Eve D. Clark, Douglas Van Daele, Henry Hoffman

    Objectives: Ultrasound-guided needle localization techniques have been used to direct the resection of targeted axillary lymph nodes in the management of breast cancer. To date, there has been only one other description of this technique as a localization method to direct cancer resection in the neck. We offer further support for the broader application of this technique by reporting its use in the successful identification and resection of recurrent papillary thyroid cancer after a paratracheal node dissection failed to localize the cancer. Methods: We report a case and discuss the relevant literature regarding ultrasound-guided localization and resection of recurrent well-differentiated thyroid cancer. Results: We were able to achieve successful identification and resection of recurrent papillary thyroid cancer using this technique. Conclusions: This technique may be useful in the treatment of selected cases of recurrent thyroid cancer to increase the efficacy and safety of surgical resection.


  • Laparoscopic Renal Tumor Cryoablation: Appropriate Application of Real-Time Ultrasonographic Monitoring

    by William J. Badger, Henrique A. Melquiades de Araujo, David M. Kuehn, Kelli J. Angresen, Howard N. Winfield

    Many authors who report outcomes of laparoscopic cryoablation for renal tumors comment that real-time intracorporeal ultrasonographic monitoring of the ice-ball formation is imperative. In our experience, ultrasonographic monitoring of the ice-ball formation necessitates significantly more mobilization of the kidney, and the images are difficult to interpret because of artifact and the cryoablation effect on the tissue. We report our intermediate outcomes for laparoscopic cryoablation without real-time ultrasonographic monitoring of the ice ball. Between December 2002 and May 2007, 27 patients underwent laparoscopic renal cryoablation. The cryoablation approach was based on tumor location and surgeon preference. Lesions were identified and overlying fat was excised, without further mobilization. Real-time ultrasonographic measurement and mapping of the renal lesion were performed. All lesions were biopsied before cryoablation. A double 10-minute freeze-thaw cycle was performed. Postoperative follow-up comprised serial imaging at months 1, 3, 6, and 12 and yearly thereafter. Mean patient age was 70.1 years with a mean renal tumor size of 2.2 cm. Sixteen (59.3%) patients had more than three comorbidities and six (22.2%) patients had two comorbidities with at least 1 previous intra-abdominal surgery. An average of four cryoablation probes were used per lesion. The serum creatinine level was 1.3 mg preoperatively and 1.4 mg at last follow-up. At follow-up of 22 months, there were no local recurrences and 1 (3%) metastatic lesion. Laparoscopic cryoablation of small renal masses continues to be a safe and effective technique, even without the use of real-time ultrasonographic monitoring of the ice ball.


  • Open Access

    Evaluation of locally recurrent pelvic malignancy: Performance of T2‐ and diffusion‐weighted MRI with image fusion

    by Akihiro Nishie, Alan H. Stolpen, Masao Obuchi, David M. Kuehn, Aaron Dagit, Kelli Andresen

    Purpose To evaluate the performance of T2- and diffusion-weighted magnetic resonance imaging (MRI) with image fusion for detection of locally recurrent pelvic malignancy. Materials and Methods The study group consisted of 28 patients (27 female, 1 male) who underwent pelvic MRI at 1.5 T after treatment of pelvic malignancy. MR images were reviewed independently by three blinded readers. The performance of the four sequences for detecting local recurrence was evaluated using receiver operating characteristic analysis: T2-weighted fast spin-echo (FSE), diffusion-weighted echo-planar imaging (DWI), dynamic contrast-enhanced (DCE) fat-suppressed T1-weighted spoiled gradient echo (SPGR), and T2-DWI with image fusion, the latter created using OsiriX Medical Imaging Software. Results Local recurrence was confirmed at biopsy in 16 patients. Twelve patients showed no evidence of recurrence on two consecutive MRI studies. The Az value for T2-DWI with image fusion (0.949) was statistically greater than that for T2-weighted FSE (0.849) (P < 0.05). The sensitivity and specificity was 87.5% and 47.2%, respectively, for T2-weighted FSE, 100.0% and 50.0% for DWI, 95.8% and 58.3% for DCE fat-suppressed T1-weighted SPGR, and 93.8% and 72.2% for T2-DWI with image fusion. Conclusion For depicting locally recurrent pelvic malignancy, T2-DWI with image fusion outperforms standard T2-weighted FSE and DWI and is comparable to DCE fat-suppressed T1-weighted SPGR. J. Magn. Reson. Imaging 2008;28:705–713.


  • Gadolinium-Enhanced Fat-Suppressed T1-Weighted Imaging for Staging Ureteral Carcinoma: Correlation with Histopathology

    by Masao Obuchi, Kousei Ishigami, Koji Takahashi, Minoru Honda, Toshiyuki Mitsuya, David M. Kuehn, Alan H. Stolpen, Bruce P. Brown, Akihiro Nishie

    OBJECTIVE. The purpose of this study was to retrospectively compare contrast-enhanced fat-suppressed T1-weighted images with histopathologic findings in ureteral carcinoma to develop accurate preoperative MR criteria for T staging. CONCLUSION. Contrast-enhanced fat-suppressed T1-weighted images can be used to distinguish thickened noncarcinomatous ureteral walls, which occur due to the proliferation of fibrous tissue, from ureteral carcinoma because fibrous tissue enhances more intensely on MRI than ureteral carcinoma. We also observed that when ureteral carcinomas had invaded periureteral fat tissue, a disruption or fragmentation of the intensely enhancing ureteral wall was seen. Using the MR criteria for T staging that we developed on the basis of these findings, we were able to accurately determine whether a carcinoma had invaded periureteral fat tissue in all of our patients.